CoChat

A single synonymous mutation determines the phosphorylation and stability of the nascent protein

Open access
Karakostis, Konstantinos, Vadivel Gnanasundram, Sivakumar, López, Ignacio, Thermou, Aikaterini, Wang, Lixiao, Nylander, Karin, Olivares-Illana, Vanesa, Fåhraeus, Robin · 2019 · Journal of Molecular Cell Biology
Cited by 52

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

p53 is an intrinsically disordered protein with a large number of post-translational modifications and interacting partners. The hierarchical order and subcellular location of these events are still poorly understood. The activation of p53 during the DNA damage response (DDR) requires a switch in the activity of the E3 ubiquitin ligase MDM2 from a negative to a positive regulator of p53. This is mediated by the ATM kinase that regulates the binding of MDM2 to the p53 mRNA facilitating an increase in p53 synthesis. Here we show that the binding of MDM2 to the p53 mRNA brings ATM to the p53 polysome where it phosphorylates the nascent p53 at serine 15 and prevents MDM2-mediated degradation of p53. A single synonymous mutation in p53 codon 22 (L22L) prevents the phosphorylation of the nascent p53 protein and the stabilization of p53 following genotoxic stress. The ATM trafficking from the nucleus to the p53 polysome is mediated by MDM2, which requires its interaction with the ribosomal proteins RPL5 and RPL11. These results show how the ATM kinase phosphorylates the p53 protein while it is being synthesized and offer a novel mechanism whereby a single synonymous mutation controls the stability and activity of the encoded protein.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjy049

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 52

  1. Bursac, 2014, Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis, Biochim. Biophys. Acta, 1842, 817, 10.1016/j.bbadis.2013.08.014 · DOI
  2. Candeias, 2008, P53 mRNA controls p53 activity by managing Mdm2 functions, Nat. Cell Biol., 10, 1098, 10.1038/ncb1770 · DOI · Paper page
  3. Cheng, 2010, Mechanism of p53 stabilization by ATM after DNA damage, Cell Cycle, 9, 472, 10.4161/cc.9.3.10556 · DOI · Paper page
  4. Coffill, 2016, The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans, Genes Dev., 30, 281, 10.1101/gad.274118.115 · DOI · Paper page
  5. Donati, 2013, 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint, Cell Rep., 4, 87, 10.1016/j.celrep.2013.05.045 · DOI · Paper page
  6. Fahraeus, 2016, Whisper mutations: cryptic messages within the genetic code, Oncogene, 35, 3753, 10.1038/onc.2015.454 · DOI
  7. Gajjar, 2012, The p53 mRNA–Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage, Cancer Cell, 21, 25, 10.1016/j.ccr.2011.11.016 · DOI · Paper page
  8. Gandin, 2014, Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale, J. Vis. Exp., 87, e51455
  9. Gartner, 2013, Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma, Proc. Natl Acad. Sci. USA, 110, 13481, 10.1073/pnas.1304227110 · DOI · Paper page
  10. Grover, 2009, p53 and little brother p53/47: linking IRES activities with protein functions, Oncogene, 28, 2766, 10.1038/onc.2009.138 · DOI
  11. Guo, 2010, Mammalian microRNAs predominantly act to decrease target mRNA levels, Nature, 466, 835, 10.1038/nature09267 · DOI · Paper page
  12. Haupt, 1997, Mdm2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 · DOI · Paper page
  13. Hosp, 2015, Quantitative interaction proteomics of neurodegenerative disease proteins, Cell Rep., 11, 1134, 10.1016/j.celrep.2015.04.030 · DOI · Paper page
  14. Joerger, 2010, The tumor suppressor p53: from structures to drug discovery, Cold Spring Harb. Perspect. Biol., 2, a000919, 10.1101/cshperspect.a000919 · DOI · Paper page
  15. Kannan, 2016, Long range recognition and selection in IDPs: the interactions of the C-terminus of p53, Sci. Rep., 6, 23750, 10.1038/srep23750 · DOI
  16. Karakostis, 2016, p53 mRNA and p53 protein structures have evolved independently to interact with MDM2, Mol. Biol. Evol., 33, 1280, 10.1093/molbev/msw012 · DOI · Paper page
  17. Komatsu, 1996, The gene for Nijmegen breakage syndrome (V2) is not located on chromosome 11, Am. J. Hum. Genet., 58, 885
  18. Koos, 2014, Analysis of protein interactions in situ by proximity ligation assays, Curr. Top. Microbiol. Immunol., 377, 111
  19. Kubbutat, 1997, Regulation of p53 stability by Mdm2, Nature, 387, 299, 10.1038/387299a0 · DOI · Paper page
  20. Kubbutat, 1999, Analysis of the degradation function of Mdm2, Cell Growth Differ., 10, 87
  21. Lambert, 1998, Phosphorylation of p53 serine 15 increases interaction with CBP, J. Biol. Chem., 273, 33048, 10.1074/jbc.273.49.33048 · DOI · Paper page
  22. Lee, 2015, Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response, Cell Res., 25, 225, 10.1038/cr.2015.8 · DOI
  23. Lindstrom, 2007, Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions, Cell Cycle, 6, 434, 10.4161/cc.6.4.3861 · DOI · Paper page
  24. Lindstrom, 2007, Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation, Mol. Cell. Biol., 27, 1056, 10.1128/MCB.01307-06 · DOI · Paper page
  25. Lopez, 2017, p53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress, Cell Death Differ., 24, 1717, 10.1038/cdd.2017.96 · DOI
  26. Loughery, 2014, Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters, Nucleic Acids Res., 42, 7666, 10.1093/nar/gku501 · DOI · Paper page
  27. MacLaine, 2011, How phosphorylation controls p53, Cell Cycle, 10, 916, 10.4161/cc.10.6.15076 · DOI
  28. Malbert-Colas, 2014, HDMX folds the nascent p53 mRNA following activation by the ATM kinase, Mol. Cell, 54, 500, 10.1016/j.molcel.2014.02.035 · DOI
  29. Matsuura, 1997, Genetic mapping using microcell-mediated chromosome transfer suggests a locus for Nijmegen breakage syndrome at chromosome 8q21-24, Am. J. Hum. Genet., 60, 1487, 10.1086/515461 · DOI
  30. Maya, 2001, ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage, Genes Dev., 15, 1067, 10.1101/gad.886901 · DOI · Paper page
  31. Medina-Medina, 2016, Allosteric interactions by p53 mRNA govern HDM2 E3 ubiquitin ligase specificity under different conditions, Mol. Cell. Biol., 36, 2195, 10.1128/MCB.00113-16 · DOI
  32. Meek, 2009, Tumour suppression by p53: a role for the DNA damage response?, Nat. Rev. Cancer, 9, 714, 10.1038/nrc2716 · DOI · Paper page
  33. Meek, 2009, Posttranslational modification of p53: cooperative integrators of function, Cold Spring Harbor Perspect. Biol., 1, a000950, 10.1101/cshperspect.a000950 · DOI · Paper page
  34. Morgan, 1997, p53 and ATM: cell cycle, cell death, and cancer, Adv. Cancer Res., 71, 1, 10.1016/S0065-230X(08)60095-0 · DOI · Paper page
  35. Naski, 2009, The p53 mRNA–Mdm2 interaction, Cell Cycle, 8, 31, 10.4161/cc.8.1.7326 · DOI
  36. Ofir-Rosenfeld, 2008, Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26, Mol. Cell, 32, 180, 10.1016/j.molcel.2008.08.031 · DOI · Paper page
  37. Pant, 2013, The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity, Genes Dev., 27, 1857, 10.1101/gad.227249.113 · DOI · Paper page
  38. Ren, 2009, DOG 1.0: illustrator of protein domain structures, Cell Res., 19, 271, 10.1038/cr.2009.6 · DOI · Paper page
  39. Saito, 2003, Phosphorylation site interdependence of human p53 post-translational modifications in response to stress, J. Biol. Chem., 278, 37536, 10.1074/jbc.M305135200 · DOI · Paper page
  40. Scott, 2002, Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer, Proc. Natl Acad. Sci. USA, 99, 925, 10.1073/pnas.012329699 · DOI · Paper page
  41. Stracker, 2013, The ATM signaling network in development and disease, Front. Genet., 4, 37, 10.3389/fgene.2013.00037 · DOI · Paper page
  42. Supek, 2014, Synonymous mutations frequently act as driver mutations in human cancers, Cell, 156, 1324, 10.1016/j.cell.2014.01.051 · DOI · Paper page
  43. Takagi, 2004, Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease, Blood, 103, 283, 10.1182/blood-2003-01-0094 · DOI
  44. Teufel, 2009, Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2, Oncogene, 28, 2112, 10.1038/onc.2009.71 · DOI · Paper page
  45. Tompa, 2002, Intrinsically unstructured proteins, Trends Biochem. Sci., 27, 527, 10.1016/S0968-0004(02)02169-2 · DOI · Paper page
  46. Tournillon, 2016, p53 binds the mdmx mRNA and controls its translation, Oncogene, 36, 723, 10.1038/onc.2016.236 · DOI
  47. Uversky, 2016, p53 proteoforms and intrinsic disorder: an illustration of the protein structure-function continuum concept, Int. J. Mol. Sci., 17, 1874, 10.3390/ijms17111874 · DOI · Paper page
  48. Weibrecht, 2013, In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay, Nat. Protoc., 8, 355, 10.1038/nprot.2013.006 · DOI
  49. Wright, 2009, Linking folding and binding, Curr. Opin. Struct. Biol., 19, 31, 10.1016/j.sbi.2008.12.003 · DOI · Paper page
  50. Yang, 2006, The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage, Oncogene, 25, 4613, 10.1038/sj.onc.1209483 · DOI
  51. Zhang, 2011, Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation, J. Biol. Chem., 286, 38264, 10.1074/jbc.M111.277012 · DOI
  52. Zhou, 2012, Scission of the p53-MDM2 loop by ribosomal proteins, Genes Cancer, 3, 298, 10.1177/1947601912455200 · DOI

Cited by

See all 52

Metadata

Authors
Karakostis, K., Vadivel Gnanasundram, S., López, I., Thermou, A., Wang, L., Nylander, K., Olivares-Illana, V., & Fåhraeus, R.
Venue
Journal of Molecular Cell Biology
Published
2018-09-24
Volume
11
Issue
3
Pages
187-199
ISSN
  • 1674-2788 (ISSN-L)
  • 1759-4685
OpenAlex
W2894539085
Cited by
52
References
16
FWCI
1.10
Type
journal article
Language
en
Open access
hybrid
Funders
National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.